期刊文献+

原发性肺癌血清骨钙素水平与骨转移的关系 被引量:6

The Study of Correlation Between Serum Osteocalcin and Bone Metastases in Patients with Lung Cancer
下载PDF
导出
摘要 目的:观察血清骨钙素水平与肺癌骨转移的关系。方法:应用Pharmacia CAP系统检测86例原发性肺癌和36例正常人血清骨钙素水平。结果:肺癌及其不同细胞类型病人之间以及与正常人比较,无骨转移者血清骨钙素水平无明显差异,伴有骨转移者血清骨钙素水平(6.26±1.68)明显高于无骨转移者(4.53±1.50)和正常人(4.56±1.53)(P<0.05)。结论:血清骨钙素检测对预示肺癌发生骨转移有参考价值。 Objective: To observe the correlation between serum level of osteocalcin and osseous metastasis caused by lung cancer.Method:The Pharmacia CAP system was employed to test the serum osteocalcin in 86 lung cancer patients and 36 healthy controls.Result:The difference of serum osteocalcin between healthy controls and patients without bone metastasis was not obviousp0.05.But the serum osteocalcin in patients with bone metastasis(6.26±1.68) were higher than those without bone metastasis(4.53±1.50) and(4.56±1.53)(P0.05).Conclusion:The serum osteocalcin could be a good indication to diagnose osseous metastasis caused by lung cancer.
出处 《河北医学》 CAS 2010年第9期1039-1041,共3页 Hebei Medicine
基金 2008年度汕头市重点科技计划项目(序号:200823)
关键词 肺癌 骨钙素 骨转移 Lung cancer Osteocalcin Osseous metastasis
  • 相关文献

参考文献5

  • 1Roodman GD.Mechanisms of bone metastasis[J].N Engl Med,2004,350(16):1655.
  • 2钱军,陈映霞,秦叔逵,何泽明,陈静波.骨转移癌149例临床分析[J].临床肿瘤学杂志,2000,5(2):120-121. 被引量:16
  • 3施为建 缪衍 潘勤 等.血清骨钙素水平与转移性骨肿瘤之间的关系.中国肿瘤临床,1998,25(2):101-101.
  • 4孙达春,张爱华,李小亮,吴红,汪丽安,赵玉成.骨转移瘤患者骨密度和血清骨代谢指标变化的临床研究[J].肿瘤研究与临床,2003,15(1):16-18. 被引量:10
  • 5Shih WJ,Wierzbinski K,Collins J,et al.Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram:comparison with serum PSA/PAP measurements[J].Nucl Med,1990,31(9):1486-1489.

二级参考文献9

共引文献23

同被引文献61

  • 1孔清泉,屠重棋,窦青瑜,汪金平,孙天威.骨转换生化指标在诊断原发性肺癌骨转移中的应用[J].四川大学学报(医学版),2005,36(3):397-399. 被引量:8
  • 2黄欣欣,蔡琳.大气污染与肺癌关系研究进展[J].中国公共卫生,2006,22(12):1443-1445. 被引量:12
  • 3徐从景.肺癌诊断新进展[J].临床肺科杂志,2007,12(8):847-849. 被引量:3
  • 4高惠璇编著.应用多元统计分析[M].北京:北京大学出版社,2006.
  • 5赵志勇,周予兰,王伟.血清骨钙素测定在肺癌骨转移诊断中的价值[J].检验医学,2007,22(4):484-485. 被引量:4
  • 6Yu S, Jiang Z, Zhang L, et ai.Chinese expert consensus statement onclinical diagnosis and treatment of malignant tumor bone metastasisand bone related diseases[J]. Chinese-German J Clin Oncol, 2010,9?1):1-12.
  • 7LiptonA.Implications of bone metastases and the benefits of bone-tar-geted therapy [J].Semin Oncol, 2010,37 (Suppl 2): S15-29.
  • 8TerposE, Kiagia M, Karapanagiotou EM,et ai.The clinical signifi-can-ce of serum markers of bone turnover in NSCLC patients : surveil —lance,management and prognostic implications [J].Anticancer Res,2009,29(5):1651-1657.
  • 9SalemAM, Zohny SF, Abd El-WalabMM, et al. Predictive value o-fosteocalcin and beta-Crosslaps in metastatic breast cancer [J]. ClinBio-chem, 2007, 40(4): 1201-1208.
  • 10akahashiS. Evaluation of cancer -induced bone diseases by bonemetabolicmarker[J]. Clin Calcium, 2006, 16(2) : 581-590.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部